drugset / Trial / NCT00750152

Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris

NCT00750152

Phase 3 Completed 334 enrolled Merz North America, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

A research study to compare the safety and effectiveness of an investigational medication called NAFT-500 to placebo (no active treatment), when used in subjects with tinea cruris, also known as jock itch.

Timeline

Start
2008-09
Primary completion
2009-08
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Naftifine Other / unclassified 2 % Topical